No abstract available
Keywords:
Cyclin-dependent kinase 4/6 inhibitor; Drug-induced vasculitis; Faslodex; Fulvestrant; Ibrance; Vasculitis treatment.
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Aged, 80 and over
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Agents, Hormonal / adverse effects
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Female
-
Fulvestrant / adverse effects
-
Fulvestrant / therapeutic use
-
Gastroenteritis / chemically induced
-
Gastroenteritis / drug therapy
-
Gastroenteritis / pathology
-
Gastroenteritis / physiopathology
-
Humans
-
Neoplasm Metastasis
-
Piperazines / adverse effects*
-
Piperazines / therapeutic use*
-
Protein Kinase Inhibitors / adverse effects
-
Protein Kinase Inhibitors / therapeutic use
-
Pyridines / adverse effects*
-
Pyridines / therapeutic use*
-
Treatment Outcome
-
Vasculitis, Leukocytoclastic, Cutaneous / chemically induced*
-
Vasculitis, Leukocytoclastic, Cutaneous / drug therapy
-
Vasculitis, Leukocytoclastic, Cutaneous / pathology
-
Vasculitis, Leukocytoclastic, Cutaneous / physiopathology
Substances
-
Adrenal Cortex Hormones
-
Antineoplastic Agents
-
Antineoplastic Agents, Hormonal
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyridines
-
Fulvestrant
-
palbociclib
Supplementary concepts
-
Erythema elevatum diutinum